Inhibikase Therapeutics, Inc. (IKT)

Inhibikase Therapeutics Revenue

• Revenue (ttm): n/a
• Revenue Growth: n/a
• P/S Ratio: n/a
• Revenue / Employee: n/a
• Employees: 16
• Market Cap: 115.50M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	-	-	-
Dec 31, 2023	260.50K	137.06K	111.03%
Dec 31, 2022	123.44K	-2.98M	-96.02%
Dec 31, 2021	3.10M	2.40M	343.92%
Dec 31, 2020	698.47K	-424.27K	-37.79%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.